| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.89B | 11.12B | 13.70B | 19.13B | 12.36B | 8.68B |
| Gross Profit | 1.86B | 1.51B | 2.21B | 5.76B | 3.20B | 1.06B |
| EBITDA | 2.97B | 1.57B | 2.48B | 5.75B | 3.23B | 1.24B |
| Net Income | 1.23B | 174.90M | 1.16B | 3.58B | 1.63B | 666.10M |
Balance Sheet | ||||||
| Total Assets | 24.67B | 22.92B | 23.03B | 23.39B | 22.04B | 19.79B |
| Cash, Cash Equivalents and Short-Term Investments | 153.30M | 272.80M | 348.80M | 735.40M | 769.50M | 574.00M |
| Total Debt | 4.80B | 4.45B | 3.99B | 3.81B | 4.41B | 4.75B |
| Total Liabilities | 11.73B | 11.31B | 10.60B | 11.19B | 11.29B | 10.03B |
| Stockholders Equity | 12.78B | 11.48B | 12.29B | 12.05B | 10.60B | 9.58B |
Cash Flow | ||||||
| Free Cash Flow | -203.70M | 47.40M | 1.00B | 2.69B | 898.40M | 412.00M |
| Operating Cash Flow | 1.10B | 1.30B | 2.41B | 3.94B | 2.19B | 1.58B |
| Investing Cash Flow | -1.30B | -1.26B | -1.32B | -1.26B | -1.32B | -1.19B |
| Financing Cash Flow | 27.30M | -131.90M | -1.48B | -2.68B | -682.10M | -283.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $12.05B | 9.31 | 27.46% | 2.61% | 12.59% | 31.40% | |
65 Neutral | $7.50B | 6.13 | 10.00% | 3.71% | 3.82% | 239.39% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | $7.36B | 20.04 | 6.15% | 3.50% | 1.77% | -8.72% | |
53 Neutral | $339.57M | ― | -33.37% | ― | 8.88% | -349.99% | |
50 Neutral | $3.04B | 21.18 | ― | 5.02% | -3.93% | ― | |
48 Neutral | $1.64B | ― | -11.52% | 17.03% | -13.42% | -136.59% |
On November 13, 2025, The Mosaic Company completed a significant financial transaction by closing the sale of $900 million in senior notes, with maturities in 2029 and 2030. The company plans to use the net proceeds of approximately $893.5 million for general corporate purposes, potentially including debt repayment, which could impact its financial flexibility and market positioning.